John Kelley
Chairman at ACORDA THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Profile
John P.
Kelley was the founder of Phyxius Pharma, Inc. (founded in 2011) where he held the title of President, Chief Executive Officer & Director from 2011 to 2013.
He is currently working as a Non-Executive Chairman at Acorda Therapeutics, Inc. since 2008.
In his former positions, Mr. Kelley served as the Chief Executive Officer & Director at Tenax Therapeutics, Inc. from 2013 to 2017, Vice President & Commercial Director-US at Hoechst Marion Roussel, Inc. from 1995 to 1999, Vice President-Marketing at Hoechst Marion Roussel SA in 1999, President & Chief Operating Officer at The Medicines Co. from 2004 to 2009, and Senior Vice President-Global Marketing & Medical at Aventis Pharmaceuticals, Inc. from 2000 to 2004.
Mr. Kelley obtained an MBA from Rockhurst University and an undergraduate degree from Wilkes University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-23 | 0 ( -.--% ) | - $ | 2024-03-30 |
John Kelley active positions
| Companies | Position | Start |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Chairman | 2019-11-24 |
Former positions of John Kelley
| Companies | Position | End |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Chief Executive Officer | 2017-04-02 |
Phyxius Pharma, Inc.
 Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The private company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Founder | 2013-11-12 |
| THE MEDICINES COMPANY | President | 2009-09-30 |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Chief Tech/Sci/R&D Officer | 2004-08-31 |
| Hoechst Marion Roussel SA | Sales & Marketing | 1999-11-30 |
Training of John Kelley
| Rockhurst University | Masters Business Admin |
| Wilkes University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| TENAX THERAPEUTICS, INC. | Health Technology |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| Hoechst Marion Roussel SA | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
Phyxius Pharma, Inc.
Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The private company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Health Technology |
- Stock Market
- Insiders
- John Kelley
